| ¿µ¹® | enzyme-linked immunoabsorbent assay | ÇÑ±Û | È¿¼Ò¸é¿ªÃøÁ¤¹ý |
|---|---|---|---|
| ¼³¸í | È¿¼Ò°áÇո鿪ÈíÂøÁ¦ °ËÁ¤¹ýÀ¸·Î ¹ø¿ªµÇ°í ÀÖ´Ù. ÀÌ ¹ýÀº Ç׿ø(¶Ç´Â Ç×ü)¿¡ ¾ËÄ®¸® Æ÷½ºÆÄŸ¾ÆÁ¦ ¶Ç´Â Æä¸£¿Á½Ãµð¾ÆÁ¦ µîÀÇ »ê¼Ò¸¦ °áÇÕ½ÃÄÑ µÎ°í ±× »ê¼ÒȰ¼ºÀ» ÁöÇ¥·Î »ï¾Æ Ç׿øÇ×ü¹ÝÀÀÀÇ Á¤µµ¸¦ ¾È ´ÙÀ½ ¿©±â¿¡¼ Ç׿ø(¶Ç´Â Ç×ü)ÀÇ ¾çÀ» ±¸ÇÏ´Â °ÍÀÌ´Ù. ÀÌ ¹ýÀÇ ÀÌÁ¡À¸·Î¼ °í°¨µµ, Á¶ÀÛÀÇ °£´ÜÇÔ ¹× ¹æ»ç¼±¸é¿ªÃøÁ¤¹ýó·³ ¹æ»ç¼º¹°ÁúÀ» »ç¿ëÇÏÁö ¾Ê¾Æµµ µÈ´Ù´Â Á¡À» µé ¼ö ÀÖ´Ù. È£¸£¸óÀ̳ª ¸é¿ª±Û·ÎºÒ¸°ÀÇ Á¤·®¹ýÀ¸·Î¼ ÀÀ¿ë µÇ°í ÀÖÀ¸¸ç ÃøÁ¤¿ë ŰƮµµ ½ÃÆÇµÇ°í ÀÌÀÖ´Ù. |
||
| hSOD | human superoxide dismutase |
|---|---|
| Mn-SOD | manganese-superoxide dismutase |
| SD | Sandhoff disease; senile dementia; septal defect; serologically defined; serologically detectable; s... |
| SOD | septo-optic dysplasia; superoxide dismutase |
| SOR | stimulus-organism response; superoxide release |
| Cu,Zn-SOD | Copper and zinc containing-superoxide dismutase |
|---|---|
| CuZnSOD | Copper zinc superoxide dismutase |
| SOD | Cu,Zn-Superoxide dismutase |
| SOD-1 | Cu,Zn-superoxide dismutase |
| EC SOD | Extracellular superoxide dismutase |
| monomethoxypolyethylene glycol-superoxide dismutase | <chemical> Pharmacological action: free radical scavengers Synonym: mpeg-sod (26 Jun 1999) |
|---|---|
| polyethylene glycol-superoxide dismutase | <chemical> A free radical scavenger Pharmacological action: free radical scavengers Synonym: peg-sod (26 Jun 1999) |
| polyhemoglobin-superoxide dismutase-catalase | <chemical> Intermolecularly cross-linked haemoglobin, superoxide dismutase and catalase; prevents methemoglobin formation and iron release Pharmacological action: free radical scavengers Synonym: polyhb-sod-catalase (26 Jun 1999) |
| polyoxyethylene-superoxide dismutase | <chemical> Recombinant human cu,zn superoxide dismutase with polyoxyethylene; decreases side effects of superoxide-generating antineoplastics such as adriamycin and mitomycin c Synonym: sod-poe, poe-sod, polyoxyethylene-modified superoxide dismutase (26 Jun 1999) |
| superoxide | <chemistry> Term used interchangeably for the superoxide anion or the weak acid HO2(.). Superoxide is generated both by prokaryotes and eukaryotes and is an important product of the metabolic burst of neutrophil leucocytes. A very active oxygen species, it can cause substantial damage and may be responsible for the inactivation of plasma antiproteases that contributes to the pathogenesis of emphysema. (18 Nov 1997) |
| superoxide anion | <chemistry> A harmful derivative of oxygen capable of oxidative destruction of cell components. (09 Oct 1997) |
| superoxide dismutase | <enzyme> Any of a range of metalloenzymes that catalyses the formation of hydrogen peroxide and oxygen from superoxide and thus protects against superoxide induced damage. Usually has either iron or manganese as the metal cation in prokaryotes, copper or zinc in eukaryotes. (18 Nov 1997) |
| zinc superoxide | ZnO2;a yellowish white powder, insoluble in water and decomposed by acids; used in pharmaceutical preparations. Synonym: zinc superoxide. (05 Mar 2000) |
| acetyl reduction assay | <investigation> A technique for measuring the nitrogen fixation activity in photosynthetic organisms. It uses a flame ionisation detector and a gas chromatography apparatus to determine the reduction of acetylene to ethylene by the enzyme nitrogenase. (06 May 1997) |
| Ames assay | <procedure> One of a number of procedures used to test substances for likely ability to cause cancer that combines the use of animal tissue to generate active metabolites of the substance with a test for mutagenicity in bacteria. (18 Nov 1997) |
| antibiotic assay | <investigation> A test to determine how sensitive a bacterial or fungal strain is to arange of antibiotics bymeasuring the microbes' ability to grow in astandard dilution of each chemical. (09 Oct 1997) |
| assay | <procedure> The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug. (10 May 1997) |
| bandshift assay | <investigation> An assay for proteins, such as transcription factors, that bind specific DNA sequences. A labelled oligonucleotide corresponding to the recognition sequence is incubated with an appropriate nuclear protein extract and run on a nondenaturing acrylamide gel. Oligonucleotides that have been bound by proteins are retarded relative to those that are unbound. (18 Nov 1997) |
| biological assay | <technique> Once a pharmaceutical protein is isolated from the cells in which it was grown, researchers perform tests to measure the protein's biological activity. It must maintain a certain minimal level of biological activity to be used for animal or clinical testing or, later, for market. Researchers also test to confirm that the isolated protein is identical to the desired protein. (21 Mar 1998) |
| radioimmunoprecipitation assay | Sensitive assay using radiolabelled antigens to detect specific antibodies in serum. The antigens are allowed to react with the serum and then precipitated using a special reagent such as protein a sepharose beads. The bound radiolabelled immunoprecipitate is then commonly analyzed by gel electrophoresis. Radioimmunoprecipitation assay (ripa) is often used as a confirmatory test for diagnosing the presence of HIV antibodies. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|